Clinical trials: flow cytometry, completed
Acquired Immunodeficiency Syndrome
Accuracy Evaluation of the BD FACS Presto System
The enumeration of T lymphocytes positive for the CD4 antigen is used to determine the immune status of patients with, or suspected of developing, immune deficiencies such as AIDS.
- Trial name
- NCT02396355
- Testing
- Investigational BD FACSPresto System, BD FACSCalibur flow cytometer, Sysmex hematology analyzer KX-21
- Where
- 6 sites in United States, India and 2 more
- Volunteers
- 583 people
- Sponsor
- Becton, Dickinson and Company
Plasma Cell Disorder
Evaluation of the Plasma Cell Disorders Panel on the BD FACSLyric™ Flow Cytometer
Multi-site, prospective performance study to determine equivalency between the investigational OneFlow PCD panel on the FACSLyric system versus the final clinical diagnosis.
- Trial name
- NCT05032339
- Testing
- IUO Plasma Cell Disorders Panel
- Where
- 5 sites in United States, Portugal and 3 more
- Volunteers
- 208 people
- Sponsor
- Becton, Dickinson and Company
Lung Neoplasm, Carcinoma, Bronchogenic
Phase II Study of Lucanix™ in Patients With Stages II-IV Non-Small Cell Lung Cancer
In this Phase II clinical trial the investigators will use four human non-small cell lung cancer cell lines that have been previously established in tissue culture laboratory.
- Trial name
- NCT01058785
- Testing
- Lucanix
- Where
- 3 sites in United States
- Volunteers
- 75 people
- Sponsor
- NovaRx Corporation
Lung Neoplasm, Carcinoma Non-small Cell Lung Cancer Stage IIIA
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Rationale: Vaccines made from gene-modified tumor cells may help the body build an immune response to kill tumor cells. It is not yet known whether vaccine therapy is more effective than a placebo as maintenance therapy in…
- Conditions
- Lung Neoplasm, Carcinoma Non-small Cell Lung Cancer Stage IIIA, Carcinoma Non-small Cell Lung Cancer Stage IIIB, Carcinoma Non-small Cell Lung Cancer Stage IV
- Trial name
- STOP (NCT00676507)
- Testing
- Lucanix™
- Where
- 82 sites in United States, Canada and 6 more
- Volunteers
- 532 people
- Sponsor
- NovaRx Corporation
Chronic Lymphoproliferative Diseases (CLPD)
Evaluation of the Chronic Lymphoproliferative Diseases Limited Panel on the BD FACSLyric™ Flow Cytometer
Multi-site, prospective performance study to determine equivalency between the investigational CLPD Limited Panel on the FACSLyric system versus the final clinical diagnosis.
- Trial name
- NCT05032313
- Testing
- IUO CLPD Limited Panel
- Where
- 6 sites in United States, Portugal and 3 more
- Volunteers
- 371 people
- Sponsor
- Becton, Dickinson and Company
Acute Leukemia
Evaluation of the BD OneFlow Acute Leukemia Panel on the BD FACSLyric Flow Cytometer
This study is a multi-site, prospective performance study to determine equivalency between the investigational OneFlow Acute Leukemia Panel on the FACSLyric system versus the final clinical diagnosis.
- Trial name
- NCT05035615
- Testing
- IUO Acute Leukemia Panel
- Where
- 8 sites in United States, Brazil and 3 more
- Volunteers
- 332 people
- Sponsor
- Becton, Dickinson and Company
Hematological Malignancy
DxFLEX 10C Clinical Study
A multi-center method comparison study is designed per CLSI-EP09 A3. This study compares the qualitative immunophenotype agreement between DxFLEX and Navios EX to demonstrate the accuracy of the DxFLEX-10C system.
- Trial name
- NCT05467449
- Testing
- DxFLEX 10C
- Where
- 6 sites in United States, Canada and 1 more
- Volunteers
- 527 people
- Sponsor
- Beckman Coulter, Inc.
Leiomyomas
Somatic Stem Cells in Leiomyomas?
The purpose of this study is to identify and characterize the Somatic Stem Cell (SSC) responsible for the formation and growth of leiomyomas using the Side Population method.
- Trial name
- NCT01592903
- Testing
- Laparoscopic myomectomy. Following analysis and proliferation of cells isolated from removed human leiomyoma.
- Where
- Spain
- Volunteers
- 16 people, healthy volunteers welcome
- Sponsor
- Igenomix
Leukemia-Lymphoma
Evaluation of ClearLLab Leukemia and Lymphoma Panels
Multi-center study of specimens from subjects presenting to the flow cytometry laboratory as part of their standard of care for hematological diseases work-up.
- Trial name
- NCT03413644
- Testing
- Flow Cytometry
- Where
- 4 sites in United States, Canada and 1 more
- Volunteers
- 482 people
- Sponsor
- Beckman Coulter, Inc.
Hematologic Malignancy, Hematologic Neoplasms
Evaluation of ClearLLab LS Screening Panel
This is a multi-center study to evaluate the clinical performance of ClearLLab LS screening panel with specimens from subjects for the diagnosis of hematologic malignancies.
- Conditions
- Hematologic Malignancy, Hematologic Neoplasms, Hematologic Diseases
- Trial name
- NCT05819762
- Testing
- Flow Cytometry
- Where
- 4 sites in China
- Volunteers
- 831 people
- Sponsor
- Beckman Coulter, Inc.